Laurie Anne Lee
CIK: 0002112716
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GENB
Generate Biomedicines, Inc.
Officer
Discretionary Trading P&L
Holdings
About Lee Laurie Anne
Lee Laurie Anne (SEC CIK 0002112716) files insider reports with the SEC as Chief Medical Officer of Generate Biomedicines, Inc. (GENB).
Signal8 holds 2 ownership filings by Lee Laurie Anne (1 Form 3, 1 Form 4), filed between Feb 26, 2026 and Mar 2, 2026. Those filings report 1 transaction, the latest on Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lee Laurie Anne's filings is in SOMERVILLE, MA.
Recent filings by Lee Laurie Anne
- Feb 26, 2026: Grant or award of GENB derivative securities (Form 4, code A).
Other insiders filing for Generate Biomedicines, Inc. (GENB)
- ARNOLD FRANCES, Director
- Pioneering Medicines 02, LLC, 10% Owner
- Nally Michael, Chief Executive Officer
- Vessey Rupert, Director
- Grous Beth, Chief People Officer
- Martin Sean, Chief Legal Officer & GC